ADVERTISEMENT

CROI 2021 — COVID-19: oral molnupiravir quickly reduces infectious virus

Pavankumar Kamat   |   Conference Report   |   16 March 2021
ADVERTISEMENT

Takeaway

  • The investigational drug molnupiravir taken twice daily for 5 days could significantly reduce infectious SARS-CoV-2 detectable in the nasopharynx.

Why this matters

  • There is an urgent need for an antiviral drug against SARS-CoV-2 that is easy to produce, transport, store, and administer.
  • Molnupiravir could potentially be the first oral...

          

Topic Challenges

left
right